193 related articles for article (PubMed ID: 2138452)
1. Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo J; Weinfeld M; Fless GM; Scanu AM
Arteriosclerosis; 1990; 10(2):240-5. PubMed ID: 2138452
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
Simon DI; Fless GM; Scanu AM; Loscalzo J
Biochemistry; 1991 Jul; 30(27):6671-7. PubMed ID: 1829635
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
Liu JN; Harpel PC; Pannell R; Gurewich V
Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
[TBL] [Abstract][Full Text] [Related]
6. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
[TBL] [Abstract][Full Text] [Related]
9. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
Hervio L; Chapman MJ; Thillet J; Loyau S; Anglés-Cano E
Blood; 1993 Jul; 82(2):392-7. PubMed ID: 8329699
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner.
Edelberg JM; Pizzo SV
Blood Coagul Fibrinolysis; 1991 Dec; 2(6):759-64. PubMed ID: 1839224
[TBL] [Abstract][Full Text] [Related]
11. Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin.
Kluft C; Jie AF; Los P; de Wit E; Havekes L
Biochem Biophys Res Commun; 1989 Jun; 161(2):427-33. PubMed ID: 2525378
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study.
Rouy D; Laplaud PM; Saboureau M; Anglés-Cano E
Arterioscler Thromb; 1992 Feb; 12(2):146-54. PubMed ID: 1531929
[TBL] [Abstract][Full Text] [Related]
14. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
Feric NT; Boffa MB; Johnston SM; Koschinsky ML
J Thromb Haemost; 2008 Dec; 6(12):2113-20. PubMed ID: 18983515
[TBL] [Abstract][Full Text] [Related]
16. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
Smith EB; Crosbie L
Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.
Marcovina SM; Koschinsky ML
Curr Opin Lipidol; 2003 Aug; 14(4):361-6. PubMed ID: 12865733
[TBL] [Abstract][Full Text] [Related]
20. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
